749 related articles for article (PubMed ID: 24508696)
1. Uveal melanoma: A pathologist's perspective and review of translational developments.
Schoenfield L
Adv Anat Pathol; 2014 Mar; 21(2):138-43. PubMed ID: 24508696
[TBL] [Abstract][Full Text] [Related]
2. Melanoma of the eye: revealing hidden secrets, one at a time.
Shields CL; Kels JG; Shields JA
Clin Dermatol; 2015; 33(2):183-96. PubMed ID: 25704938
[TBL] [Abstract][Full Text] [Related]
3. The Interdisciplinary Diagnosis and Treatment of Intraocular Tumors.
Bornfeld N; Biewald E; Bauer S; Temming P; Lohmann D; Zeschnigk M
Dtsch Arztebl Int; 2018 Feb; 115(7):106-111. PubMed ID: 29510820
[TBL] [Abstract][Full Text] [Related]
4. Uveal metastasis revealing lung cancer.
Meziani L; Cassoux N; Le Rouic LL; Gabriel CL; Dendale R; Sastre X; Catherine D; Livartowski A; Plancher C; Asselain B; Desjardins L
J Fr Ophtalmol; 2012 Jun; 35(6):420-5. PubMed ID: 22633214
[TBL] [Abstract][Full Text] [Related]
5. Metastatic melanoma in the eye and orbit.
Zografos L; Ducrey N; Beati D; Schalenbourg A; Spahn B; Balmer A; Othenin-Girard CB; Chamot L; Egger E
Ophthalmology; 2003 Nov; 110(11):2245-56. PubMed ID: 14597536
[TBL] [Abstract][Full Text] [Related]
6. Epidemiology and management of uveal melanoma.
Yonekawa Y; Kim IK
Hematol Oncol Clin North Am; 2012 Dec; 26(6):1169-84. PubMed ID: 23116575
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis and treatment of uveal melanoma.
Shields JA; Shields CL; De Potter P; Singh AD
Semin Oncol; 1996 Dec; 23(6):763-7. PubMed ID: 8970600
[TBL] [Abstract][Full Text] [Related]
8. Non-ocular primary malignancies in patients with uveal melanoma: the Liverpool experience.
Heussen FM; Coupland SE; Kalirai H; Damato BE; Heimann H
Br J Ophthalmol; 2016 Mar; 100(3):356-9. PubMed ID: 26178903
[TBL] [Abstract][Full Text] [Related]
9. Expression of the metastasis suppressor gene KISS1 in uveal melanoma.
Martins CM; Fernandes BF; Antecka E; Di Cesare S; Mansure JJ; Marshall JC; Burnier MN
Eye (Lond); 2008 May; 22(5):707-11. PubMed ID: 18219339
[TBL] [Abstract][Full Text] [Related]
10. Elevated blood β-2 microglobulin is associated with tumor monosomy-3 in patients with primary uveal melanoma.
Triozzi PL; Elson P; Aldrich W; Achberger S; Tubbs R; Biscotti CV; Singh AD
Melanoma Res; 2013 Feb; 23(1):1-7. PubMed ID: 23196330
[TBL] [Abstract][Full Text] [Related]
11. MHC class II-transduced tumor cells originating in the immune-privileged eye prime and boost CD4(+) T lymphocytes that cross-react with primary and metastatic uveal melanoma cells.
Bosch JJ; Thompson JA; Srivastava MK; Iheagwara UK; Murray TG; Lotem M; Ksander BR; Ostrand-Rosenberg S
Cancer Res; 2007 May; 67(9):4499-506. PubMed ID: 17483366
[TBL] [Abstract][Full Text] [Related]
12. Malignant tumors of the uveal tract.
Shields JA; Young SE
Curr Probl Cancer; 1980 Jul; 5(1):1-35. PubMed ID: 6996936
[TBL] [Abstract][Full Text] [Related]
13. Matrix metalloproteinase-2 (MMP-2) immunoreactive protein--a new prognostic marker in uveal melanoma?
Väisänen A; Kallioinen M; von Dickhoff K; Laatikainen L; Höyhtyä M; Turpeenniemi-Hujanen T
J Pathol; 1999 May; 188(1):56-62. PubMed ID: 10398141
[TBL] [Abstract][Full Text] [Related]
14. Histopathologic, immunohistochemical, and cytogenetic analysis of primary clear cell melanoma of the uvea.
Verdijk RM; Koopmans AE; Kilic E; Paridaens D; de Klein A
JAMA Ophthalmol; 2013 Jun; 131(6):814-6. PubMed ID: 23579462
[No Abstract] [Full Text] [Related]
15. Ocular melanoma.
Laver NV; McLaughlin ME; Duker JS
Arch Pathol Lab Med; 2010 Dec; 134(12):1778-84. PubMed ID: 21128775
[TBL] [Abstract][Full Text] [Related]
16. Current molecular and clinical insights into uveal melanoma (Review).
Fallico M; Raciti G; Longo A; Reibaldi M; Bonfiglio V; Russo A; Caltabiano R; Gattuso G; Falzone L; Avitabile T
Int J Oncol; 2021 Apr; 58(4):. PubMed ID: 33649778
[TBL] [Abstract][Full Text] [Related]
17. Inhibitor of apoptosis proteins gene expression and its correlation with prognostic factors in primary and metastatic uveal melanoma.
Lederman M; Meir T; Zeschnigk M; Pe'er J; Chowers I
Curr Eye Res; 2008 Oct; 33(10):876-84. PubMed ID: 18853322
[TBL] [Abstract][Full Text] [Related]
18. [The pathological basis of the argument in the treatment of melanoma of the uveal tract].
Li YP
Zhonghua Yan Ke Za Zhi; 2012 Nov; 48(11):971-5. PubMed ID: 23302268
[TBL] [Abstract][Full Text] [Related]
19. Uveal melanoma dormancy: an acceptable clinical endpoint?
Blanco PL; Lim LA; Miyamoto C; Burnier MN
Melanoma Res; 2012 Oct; 22(5):334-40. PubMed ID: 22895346
[TBL] [Abstract][Full Text] [Related]
20. An immunohistochemical and prognostic analysis of cytokeratin expression in malignant uveal melanoma.
Fuchs U; Kivelä T; Summanen P; Immonen I; Tarkkanen A
Am J Pathol; 1992 Jul; 141(1):169-81. PubMed ID: 1378696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
